Nissay Asset Management Corp Japan Reduces Position in Agilent Technologies, Inc. $A

Nissay Asset Management Corp Japan decreased its position in Agilent Technologies, Inc. (NYSE:A) by 64.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 37,875 shares of the medical research company’s stock after selling 69,767 shares during the period. Nissay Asset Management Corp Japan’s holdings in Agilent Technologies were worth $5,031,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in A. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares during the last quarter. Bank of Nova Scotia purchased a new position in Agilent Technologies during the 2nd quarter valued at about $58,539,000. Dudley & Shanley Inc. raised its position in Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after purchasing an additional 14,300 shares during the last quarter. BIP Wealth LLC bought a new position in Agilent Technologies during the 2nd quarter valued at approximately $834,000. Finally, Crossmark Global Holdings Inc. lifted its holdings in Agilent Technologies by 39.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after buying an additional 9,615 shares during the period.

Agilent Technologies Price Performance

Shares of A stock opened at $154.47 on Monday. The stock has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.34 and a beta of 1.25. The business’s fifty day moving average is $140.30 and its 200 day moving average is $127.04. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $163.75. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter last year, the firm posted $1.37 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on A shares. Citigroup lifted their price objective on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday. Barclays raised their price target on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Thursday. Sanford C. Bernstein lifted their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $170.33.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.